Drug intelligence / Profile preview

citalopram + gabapentin

Development stage
Unknown
Lead developer
Lundbeck
Administration
Oral
01

Overview

The combination of citalopram and gabapentin is used in clinical practice, though it comes with certain interaction considerations. Citalopram is a selective serotonin reuptake inhibitor (SSRI) antidepressant, while gabapentin is an anticonvulsant medication that's also used for nerve pain. When taken together, these medications may cause additive central nervous system (CNS) depression, potentially increasing the risk of side effects such as drowsiness, dizziness, and impaired judgment or thinking skills[1][2]. The concern is that both medications suppress the nervous system, and when combined, the effect might be greater than the sum of their individual effects (described as "1 + 1 = 3")[2]. ## Pharmacological Information **Citalopram** is FDA-approved for treating adults with major depressive disorder, though it's used off-label for various conditions including obsessive-compulsive disorder, social anxiety disorder, panic disorder, and diabetic neuropathy[4]. It works by inhibiting the central uptake of serotonin in the CNS[4]. **Gabapentin** is FDA-approved for: - Treatment of postherpetic neuralgia in adults - Adjunctive treatment of partial-onset seizures in patients 3 years and older in the US - Various types of peripheral neuropathic pain, such as painful diabetic neuropathy[3] It's also commonly prescribed off-label for anxiety, insomnia, and various pain conditions. ## Interaction Considerations The interaction between citalopram and gabapentin is classified as having potential clinical significance. Key points about this interaction include: 1. **CNS Depression**: Both medications can cause CNS depression, which may be additive when taken together[1][3][4]. 2. **Management**: Healthcare providers should monitor patients for increased sedation or other CNS depressant effects when these medications are used concurrently[1]. 3. **No Contraindication**: While caution is advised, the combination is not absolutely contraindicated. Many patients take both medications without significant problems[2]. 4. **Practical Experience**: Forum discussions indicate that some patients are prescribed both medications together by their neurologists without experiencing problems[2]. ## Safety Considerations When taking citalopram and gabapentin together: 1. **Monitor for Side Effects**: Watch for increased drowsiness, dizziness, or impaired coordination, especially when starting the combination[1][2]. 2. **Avoid Alcohol**: Alcohol should be avoided as it can further increase CNS depression when combined with either medication[3][6]. 3. **Other Medications**: Be cautious about adding other medications that can cause CNS depression, such as opioids, benzodiazepines, or antihistamines[6][7]. 4. **Antacids**: If taking antacids, they should be taken at least 2 hours before or after gabapentin to prevent reduced absorption of gabapentin[7]. 5. **Recreational Drugs**: Avoid recreational drugs as gabapentin can intensify their effects and increase the risk of side effects like panic attacks, anxiety, and memory loss[7]. Unlike some other antidepressants that are potent CYP2D6 inhibitors, citalopram appears to have less potential for certain drug interactions. A study examining tamoxifen metabolism found that while citalopram did decrease plasma concentrations of an active tamoxifen metabolite, gabapentin did not have this effect[5]. In summary, while citalopram and gabapentin can be used together, patients should be monitored for increased CNS depression, and the combination should be used with caution, especially in elderly patients or those taking other CNS depressants.

02

Targets

CACNA2D2 (α2δ-2)SERT (Sodium-dependent serotonin transporter)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)

Beyond the preview

Go deeper on citalopram + gabapentin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on citalopram + gabapentin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call